Major Growth Driver Identified in 2025 Gastrointestinal Pathogen Testing Market: Impact Of Foodborne Diseases On The Gastrointestinal Pathogen Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gastrointestinal Pathogen Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for testing gastrointestinal pathogens has experienced consistent growth over the past few years. It is projected to increase from a value of $4.05 billion in 2024 to $4.24 billion in 2025, marking a compound annual growth rate (CAGR) of 4.6%. The expansion during the historic period was largely due to a higher incidence of gastrointestinal illnesses, increased awareness regarding illnesses from contaminated food, enhance in travel-related infections because of globalization, policy measures aimed at food safety, an increase in healthcare spending, and a surge in the need for quick and precise diagnostic solutions.

Gastrointestinal Pathogen Testing Market Size Forecast: What's the Projected Valuation by 2029?
The market size for testing gastrointestinal pathogens is set to experience consistent expansion in the upcoming years, reaching $5.01 billion in 2029 with a 4.3% CAGR. The anticipated growth can be credited to factors such as the rising incidence of gastrointestinal infections across the globe, increased consciousness regarding the significance of early identification and treatment, enhancement in healthcare facilities in developing economies, the surged demand for point-of-care testing alternatives, strong emphasis on food safety regulations, and persistent R&D initiatives. The forecast period will witness trends such as swift testing techniques, the escalating use of molecular diagnostic methods, the widening of point-of-care testing in unconventional healthcare locations, progress in automation and robotics for simplified testing procedures, the advent of innovative biomarkers for improved pathogen identification, and the incorporation of artificial intelligence and machine-learning algorithms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

What Are the Drivers Transforming the Gastrointestinal Pathogen Testing Market?
The expansion of the gastrointestinal pathogen testing market is predicted to be driven by the increasing occurrences of foodborne illnesses. These diseases, including listeriosis, viral gastroenteritis, taeniasis, and trichinosis, are often the result of consuming food or drink contaminated with harmful microorganisms, toxins, or chemicals. The surge in episodes of foodborne illnesses can be attributed to various factors, such as shifts in food production, distribution, and consumption, insufficient safety measures for food, and climate change's effects on food yield. Gastrointestinal testing plays a crucial role in detecting the specific pathogens causing these diseases, allowing healthcare practitioners to pinpoint the source of gastrointestinal discomfort, prescribe suitable treatments, trace disease outbreaks, and put in place preventative measures to diminish the spread of foodborne illnesses. For example, there were 167 reported cases of listeriosis in 2022 in England and Wales, an increase from 160 in 2021, as per the data from the UK Health Security Agency, a UK-based governmental organization, in February 2024. Consequently, the escalating incidents of foodborne diseases are propelling the growth of the gastrointestinal pathogen testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

What Long-Term Trends Will Define the Future of the Gastrointestinal Pathogen Testing Market?
Major players in the gastrointestinal pathogen testing market are focussing their efforts on creating sophisticated solutions like metagenomic diagnostic tests, as these increase the precision, speed, and thoroughness of identifying gastrointestinal pathogens. A metagenomic diagnostic test is a cutting-edge methodology for scrutinizing the genetic content of microbes in various samples, such as stool or blood. For example, Microba Life Sciences, an Australian biotech firm, launched MetaPanel in April 2024. It's a metagenomic diagnostic test that accurately identifies a broad spectrum of gastrointestinal pathogens. By covering 175 pathogen targets in a single examination, MetaPanel provides a full-fledged solution for diagnosing both regular and difficult-to-identify infections to health professionals. The test utilizes next-generation sequencing (NGS) technology to study a wide range of genetic data in a stool sample, enabling it to identify an extensive array of potential pathogens, some of which aren't usually covered in conventional GI (gastrointestinal) panels.

Which Segments in the Gastrointestinal Pathogen Testing Market Offer the Most Profit Potential?
The gastrointestinal pathogen testing market covered in this report is segmented -

1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp

Which Firms Dominate the Gastrointestinal Pathogen Testing Market by Market Share and Revenue in 2025?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Which Regions Offer the Highest Growth Potential in the Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.